NO961274L - Azolderivat og farmasöytiske preparat derav - Google Patents

Azolderivat og farmasöytiske preparat derav

Info

Publication number
NO961274L
NO961274L NO961274A NO961274A NO961274L NO 961274 L NO961274 L NO 961274L NO 961274 A NO961274 A NO 961274A NO 961274 A NO961274 A NO 961274A NO 961274 L NO961274 L NO 961274L
Authority
NO
Norway
Prior art keywords
different
same
pharmaceutical preparations
lower alkyl
azole derivatives
Prior art date
Application number
NO961274A
Other languages
English (en)
Norwegian (no)
Other versions
NO961274D0 (no
Inventor
Minoru Okada
Toru Yoden
Eiji Kawaminami
Yoshiaki Shimada
Tsukasa Ishihara
Masafumi Kudou
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO961274L publication Critical patent/NO961274L/no
Publication of NO961274D0 publication Critical patent/NO961274D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961274A 1993-09-30 1996-03-29 Azolderivat og farmasöytiske preparat derav NO961274D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24494493 1993-09-30
PCT/JP1994/001593 WO1995009157A1 (fr) 1993-09-30 1994-09-28 Derive d'azole et composition pharmaceutique le contenant

Publications (2)

Publication Number Publication Date
NO961274L true NO961274L (no) 1996-03-29
NO961274D0 NO961274D0 (no) 1996-03-29

Family

ID=17126291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961274A NO961274D0 (no) 1993-09-30 1996-03-29 Azolderivat og farmasöytiske preparat derav

Country Status (12)

Country Link
US (1) US5807880A (xx)
EP (1) EP0721943A4 (xx)
KR (1) KR960704852A (xx)
CN (1) CN1131944A (xx)
AU (1) AU679119B2 (xx)
CA (1) CA2170874A1 (xx)
FI (1) FI961418A0 (xx)
HU (1) HUT75871A (xx)
NO (1) NO961274D0 (xx)
NZ (1) NZ273681A (xx)
PL (1) PL313769A1 (xx)
WO (1) WO1995009157A1 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3784997A (en) 1996-08-09 1998-03-06 Eisai Co. Ltd. Benzopiperidine derivatives
ATE231128T1 (de) * 1997-02-21 2003-02-15 Takeda Chemical Industries Ltd Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
NZ501822A (en) * 1997-10-02 2001-12-21 Yukijirushi Nyugyo Kabushiki K Therapeutic agents for male and female sex hormone dependent diseases
US6559157B2 (en) 1997-10-02 2003-05-06 Daiichi Pharmaceutical Co., Ltd. Dihydronaphthalene compounds
JP4546589B2 (ja) * 1998-04-23 2010-09-15 武田薬品工業株式会社 ナフタレン誘導体
EP1073640B1 (en) * 1998-04-23 2005-04-13 Takeda Pharmaceutical Company Limited Naphthalene derivatives, their production and use
ATE321552T1 (de) 1999-10-22 2006-04-15 Takeda Pharmaceutical 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
PE20010781A1 (es) 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
JP4520012B2 (ja) * 1999-10-22 2010-08-04 武田薬品工業株式会社 1−置換−1−(1h−イミダゾール−4−イル)メタノール類
CN1329394C (zh) 2000-11-17 2007-08-01 武田药品工业株式会社 新咪唑衍生物、其制备方法及其用途
ATE502030T1 (de) 2000-11-20 2011-04-15 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
EP1348706B1 (en) 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
WO2004082679A1 (ja) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited 放出制御組成物
WO2008021250A2 (en) * 2006-08-10 2008-02-21 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
ES2475945T3 (es) 2009-06-26 2014-07-11 Novartis Ag Derivados imidazolidin-2 -ona 1,3-disustituida como inhibidores de CYP 17
WO2011041737A2 (en) 2009-10-02 2011-04-07 Fred Hutchinson Cancer Research Center Gain-of-function bcl-2 inhibitors
WO2011041731A2 (en) 2009-10-02 2011-04-07 Fred Hutchinson Cancer Research Center Method of inhibiting bcl-2-related survival proteins
KR101926320B1 (ko) 2010-08-04 2018-12-06 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
WO2012035078A1 (en) 2010-09-16 2012-03-22 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
BR112013014484A2 (pt) * 2010-12-13 2016-07-19 Viamet Pharmaceuticals Inc compostos inibidores de metaloenzimas
CA2834224A1 (en) 2011-04-28 2012-11-01 Novartis Ag 17.alpha.-hydroxylase/c17,20-lyase inhibitors
JP5990059B2 (ja) * 2012-08-03 2016-09-07 花王株式会社 StAR発現抑制剤
JP6275378B2 (ja) * 2012-12-26 2018-02-07 エヌ・イーケムキャット株式会社 カルバゾール類の製造方法およびこの方法により製造されたカルバゾール類。
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
WO2018080933A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
CA3098219C (en) * 2018-04-27 2024-05-07 Chengdu Henghao Investment Co. Limited A 10h-phenothiazine ferroptosis inhibitor as well as the preparative method and the use thereof
CN109748884B (zh) * 2019-02-19 2022-06-24 成都恒昊创新科技有限公司 一种铁死亡抑制剂及其制备方法与应用
WO2021098715A1 (zh) * 2019-11-21 2021-05-27 成都恒昊投资有限公司 一种吩噻嗪类铁死亡抑制剂及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
DE3942227A1 (de) * 1989-12-21 1991-06-27 Bayer Ag Triarylmethan-farbbildner
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
AU7275894A (en) * 1993-08-04 1995-02-28 Yamanouchi Pharmaceutical Co., Ltd. Imidazolylalkylamine derivative and pharmaceutical composition thereof

Also Published As

Publication number Publication date
AU679119B2 (en) 1997-06-19
KR960704852A (ko) 1996-10-09
US5807880A (en) 1998-09-15
EP0721943A1 (en) 1996-07-17
CA2170874A1 (en) 1995-04-06
NZ273681A (en) 1996-09-25
HUT75871A (en) 1997-05-28
PL313769A1 (en) 1996-07-22
HU9600813D0 (en) 1996-05-28
NO961274D0 (no) 1996-03-29
FI961418A (fi) 1996-03-29
CN1131944A (zh) 1996-09-25
WO1995009157A1 (fr) 1995-04-06
FI961418A0 (fi) 1996-03-29
EP0721943A4 (en) 1996-09-04
AU7707194A (en) 1995-04-18

Similar Documents

Publication Publication Date Title
NO961274L (no) Azolderivat og farmasöytiske preparat derav
NO20065784L (no) Steroidforbindelser og anvendelse av slike
EP1125932A8 (en) Substituted thiazoles for the treatment of inflammation
WO2002064547A3 (en) Isophthalic acid derivatives as matrix metalloproteinase inhibitors
BG85550A (bg) 2-анилино-пиримидинови производни
ES2187473T3 (es) Triarylimidazoles.
HUP0000063A2 (hu) Fenilcsoportokkal diszubsztituált diazolok és biazolok mint káliumcsatorna modulátorok és ezeket tartalmazó gyógyszerkészítmények
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
IL160700A0 (en) 3-substituted-4-pyrimidone derivatives
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
WO2002076440A3 (en) Methods of treating alzheimer's disease with piperidin derivates
CA2377803A1 (en) Phenyl sulfamate derivatives
NO20010203L (no) Diacylhydrazinderivater som integrininhibitorer
DK1077218T3 (da) Peptidomimetiske forbindelser omfattende RGD-sekvenser, som er nyttige som integrininhibitorer
DK534381A (da) Fremgangsmaade til fremstilling af 2-oxoazetidinderivater
NO20043211L (no) Imidazo [1,2-a]pyridinderivat
DE69107064D1 (de) Indolderivate.
WO2001023392A8 (en) Tetracyclic benzimidazole derivatives and combinatorial libraries thereof
CA2139731A1 (en) 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
IL108387A (en) Optically active beta-aminoalkoxyborane complex and its use in organic synthesis
NO973980L (no) Imidazolderivater og medisinsk preparat
FI955118A (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
MXPA03011399A (es) Metodos para tratar la enfermedad de alzheimer.
NO983283L (no) Hydrokamsyre-baserte Kollagenase-inhibitorer